Endologix (ELGX) Misses Q4 EPS by 6c

Go back to Endologix (ELGX) Misses Q4 EPS by 6c

Endologix (ELGX) Complelling Ahead of H216 Catalysts, but Risks Remain - BTIG

February 23, 2016 11:09 AM EST

BTIG affirmed its Buy rating and $14 price target on Endologix (Nasdaq: ELGX) following the company reported Q4 results late... More